Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-Obesity Prescription Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-Obesity Prescription Drugsmarket, defines the market attractiveness level of Anti-Obesity Prescription Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-Obesity Prescription Drugs industry, describes the types of Anti-Obesity Prescription Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-Obesity Prescription Drugs market and the development prospects and opportunities of Anti-Obesity Prescription Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-Obesity Prescription Drugs market in Chapter 13.
By Player:
Novo Nordisk
Arena Pharmaceuticals
VIVUS
F Hoffmann La Roche
Orexigen Therapeutics
By Type:
Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide
By End-User:
Hospitals Pharmacies
Retail Pharmacies
E-commerce
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-Obesity Prescription Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-Obesity Prescription Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-Obesity Prescription Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-Obesity Prescription Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-Obesity Prescription Drugs Market Analysis and Outlook to 2022
-
7.1 Global Anti-Obesity Prescription Drugs Consumption (2017-2022)
-
7.2 United States Anti-Obesity Prescription Drugs Consumption (2017-2022)
-
7.3 Europe Anti-Obesity Prescription Drugs Consumption (2017-2022)
-
7.4 China Anti-Obesity Prescription Drugs Consumption (2017-2022)
-
7.5 Japan Anti-Obesity Prescription Drugs Consumption (2017-2022)
-
7.6 India Anti-Obesity Prescription Drugs Consumption (2017-2022)
-
7.7 South Korea Anti-Obesity Prescription Drugs Consumption (2017-2022)
8 Region and Country-wise Anti-Obesity Prescription Drugs Market Analysis and Outlook to 2028
-
8.1 Global Anti-Obesity Prescription Drugs Consumption Forecast (2022-2028)
-
8.2 United States Anti-Obesity Prescription Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Anti-Obesity Prescription Drugs Consumption Forecast (2022-2028)
-
8.4 China Anti-Obesity Prescription Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Anti-Obesity Prescription Drugs Consumption Forecast (2022-2028)
-
8.6 India Anti-Obesity Prescription Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-Obesity Prescription Drugs Consumption Forecast (2022-2028)
9 Global Anti-Obesity Prescription Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-Obesity Prescription Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bupropion and Naltrexone Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Orlistat Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lorcaserin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Phentermine and Topiramate Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Liraglutide Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-Obesity Prescription Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global E-commerce Consumption and Growth Rate (2017-2022)
10 Global Anti-Obesity Prescription Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-Obesity Prescription Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Bupropion and Naltrexone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Orlistat Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Lorcaserin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Phentermine and Topiramate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Liraglutide Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-Obesity Prescription Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global E-commerce Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-Obesity Prescription Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-Obesity Prescription Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-Obesity Prescription Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-Obesity Prescription Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-Obesity Prescription Drugs Market Competitive Analysis
-
14.1 Novo Nordisk
-
14.1.1 Novo Nordisk Company Details
-
14.1.2 Novo Nordisk Anti-Obesity Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novo Nordisk Anti-Obesity Prescription Drugs Product and Service
-
14.2 Arena Pharmaceuticals
-
14.2.1 Arena Pharmaceuticals Company Details
-
14.2.2 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product and Service
-
14.3 VIVUS
-
14.3.1 VIVUS Company Details
-
14.3.2 VIVUS Anti-Obesity Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 VIVUS Anti-Obesity Prescription Drugs Product and Service
-
14.4 F Hoffmann La Roche
-
14.4.1 F Hoffmann La Roche Company Details
-
14.4.2 F Hoffmann La Roche Anti-Obesity Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 F Hoffmann La Roche Anti-Obesity Prescription Drugs Product and Service
-
14.5 Orexigen Therapeutics
-
14.5.1 Orexigen Therapeutics Company Details
-
14.5.2 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-Obesity Prescription Drugs
-
Figure Anti-Obesity Prescription Drugs Picture
-
Table Global Anti-Obesity Prescription Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Obesity Prescription Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Obesity Prescription Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-Obesity Prescription Drugs Consumption by Country (2017-2022)
-
Figure United States Anti-Obesity Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-Obesity Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Anti-Obesity Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-Obesity Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Anti-Obesity Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-Obesity Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Obesity Prescription Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-Obesity Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-Obesity Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-Obesity Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-Obesity Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-Obesity Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-Obesity Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bupropion and Naltrexone Consumption and Growth Rate (2017-2022)
-
Figure Global Orlistat Consumption and Growth Rate (2017-2022)
-
Figure Global Lorcaserin Consumption and Growth Rate (2017-2022)
-
Figure Global Phentermine and Topiramate Consumption and Growth Rate (2017-2022)
-
Figure Global Liraglutide Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global E-commerce Consumption and Growth Rate (2017-2022)
-
Figure Global Bupropion and Naltrexone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Orlistat Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lorcaserin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phentermine and Topiramate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liraglutide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global E-commerce Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-Obesity Prescription Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-Obesity Prescription Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Anti-Obesity Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Anti-Obesity Prescription Drugs Product and Service
-
Table Arena Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product and Service
-
Table VIVUS (Foundation Year, Company Profile and etc.)
-
Table VIVUS Anti-Obesity Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table VIVUS Anti-Obesity Prescription Drugs Product and Service
-
Table F Hoffmann La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann La Roche Anti-Obesity Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann La Roche Anti-Obesity Prescription Drugs Product and Service
-
Table Orexigen Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orexigen Therapeutics Anti-Obesity Prescription Drugs Product and Service
-
